Molecular mechanism of statin-mediated LOX-1 inhibition.
about
Caveolae and Caveolin-1 Integrate Reverse Cholesterol Transport and Inflammation in AtherosclerosisStructure-based Design Targeted at LOX-1, a Receptor for Oxidized Low-Density Lipoprotein.The lectin-like oxidized LDL receptor-1: a new potential molecular target in colorectal cancerLOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies.Membrane Cholesterol Modulates LOX-1 Shedding in Endothelial CellsMultiple molecular dynamics simulations of human LOX-1 and Trp150Ala mutant reveal the structural determinants causing the full deactivation of the receptor.
P2860
Molecular mechanism of statin-mediated LOX-1 inhibition.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Molecular mechanism of statin-mediated LOX-1 inhibition.
@ast
Molecular mechanism of statin-mediated LOX-1 inhibition.
@en
type
label
Molecular mechanism of statin-mediated LOX-1 inhibition.
@ast
Molecular mechanism of statin-mediated LOX-1 inhibition.
@en
prefLabel
Molecular mechanism of statin-mediated LOX-1 inhibition.
@ast
Molecular mechanism of statin-mediated LOX-1 inhibition.
@en
P2093
P2860
P50
P1433
P1476
Molecular mechanism of statin-mediated LOX-1 inhibition.
@en
P2093
Francesco Oteri
Giulia Vindigni
Sara Matarazzo
P2860
P304
P356
10.1080/15384101.2015.1026486
P577
2015-01-01T00:00:00Z